All drug development articles
-
WebinarHow to profit from recent innovations in small molecule drug discovery
Reduce risk, cost and wasted time in the new era of small molecule drug discovery
-
WebinarAutomated capsule chemistry with Synple: do more, faster
Synple’s automated synthesis technology allows discovery chemists to accelerate research and improve efficiency
-
WebinarHarness the power of electricity to make organic compounds
Join us to learn how to use batch-type cells in preparatory electrosynthesis
-
OpinionRuling out the rule of five
Simple calculations for clinical trial success failed to find a winning formula
-
ArticlePharmaceutical impurities: Combatting pharma’s elusive threat
Small molecule manufacturer Toronto Research Chemicals helps drug formulators eliminate impurities in the development pipeline, ensuring safer products make it to market
-
WebinarDeveloping small-molecule degraders using chemoproteomics
Discover how chemoproteomics can inform the development of small molecule degraders
-
ArticleCatalysis and chemical bonds that make us stronger
Chemical and pharma industry is built on collaboration that draws on a wide range of expertise to develop innovative materials, compounds and components
-
PodcastCimetidine
Mike Freemantle introduces the peptic ulcer treatment cimetidine, which – as Tagamet – became the first blockbuster drug
-
PodcastFexinidazole
The World Health Organisation hope to eradicate sleeping sickness within our lifetimes. Jamie Durrani looks at a drug that may make it possible.
-
ArticleCultivating innovation in the UK’s life science industry
Scientific and digital collaboration is key to maintaining the UK’s esteemed status in global life sciences and pharma circles. CPI exists to facilitate and underpin those vital relationships
-
ArticleAgeing populations and the medicines of tomorrow
Drug particle engineering is set to revolutionise medicine and provide solutions to the world’s biggest healthcare challenges. Scientific innovator Nanoform is a vital part of that movement. Here’s why
-
ArticleSeeking part-time scientists with GMP skills
Experienced scientists who opt to work part time are so beneficial to Reading Scientific Service Ltd that the company wants more of them
-
ArticleJohnson Matthey enzyme technology for a clean and healthy tomorrow
Enzymes have evolved into nature’s reaction facilitators over millions of years and their unique catalytic abilities drive science by connecting essential life elements
-
WebinarSynthia: Retrosynthesis software for research chemists
This computer-aided approach efficiently searches possible pathways for target molecules to accelerate drug discovery
-
ResearchNew ligand removes uranium from bones
A treatment that mops up uranium in the bones and kidneys of mice could help humans exposed to radiation
-
ArticleHow biologics have changed the rules for pharma
The impact of the latest generation of drugs for the healthcare industry
-
NewsVaccines central to efforts to head off latest Ebola outbreak
Ring vaccination strategy could halt disease in its tracks provided health systems can cope
-
ArticleSygnature Discovery
Sygnature Discovery is part of an innovative partnership to bolster the life science sector in Nottingham
-
WhitepaperAnalytical method transfer
Learn about current best practice in a critical field for the industry
-
ResearchDrug binding simulations promise to get personal
Fast, reliable new molecular dynamic simulation methods set to speed up research are under investigation by GSK